Cargando…
Identification of key pathways and biomarkers in sorafenib-resistant hepatocellular carcinoma using bioinformatics analysis
Hepatocellular carcinoma (HCC) is one of the most common malignant types of cancer, with a high mortality rate. Sorafenib is the sole approved oral clinical therapy against advanced HCC. However, individual patients exhibit varying responses to sorafenib and the development of sorafenib resistance h...
Autores principales: | Huang, Danping, Yuan, Weiqu, Li, Hanmin, Li, Shaodong, Chen, Zuanguang, Yang, Hongzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122189/ https://www.ncbi.nlm.nih.gov/pubmed/30186410 http://dx.doi.org/10.3892/etm.2018.6427 |
Ejemplares similares
-
Developmental Toxicity of Diethylnitrosamine in Zebrafish Embryos/Juveniles Related to Excessive Oxidative Stress
por: Huang, Danping, et al.
Publicado: (2018) -
Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis
por: Li, Lin, et al.
Publicado: (2017) -
Identification and validation of potential key long noncoding RNAs in sorafenib-resistant hepatocellular carcinoma cells
por: Wu, Manya, et al.
Publicado: (2020) -
Identification of key genes and pathways in hepatocellular carcinoma: A preliminary bioinformatics analysis
por: Wu, Min, et al.
Publicado: (2019) -
Identification of key snoRNAs serves as biomarkers for hepatocellular carcinoma by bioinformatics methods
por: Xie, Qingqing, et al.
Publicado: (2022)